| [1] Brown C J, Lain S, Verma C S, et al. Awakening guardian angels: drugging the p53 pathway. Nat Rev Cancer, 2009, 9(12):862-873.
[2] Bartel D P. MicroRNAs: target recognition and regulatory functions. Cell,2009, 136(2):215-233.
[3] Lee R C, Feinbaum R L, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell,1993,75(5):843-854.
[4] Zhu W, Shan X, Wang T, et al. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int J Cancer,2010, .
[5] Barbarotto E, Schmittgen T D, Calin G A. MicroRNAs and cancer: profile, profile, profile. Int J Cancer,2008, 122(5):969-977.
[6] Tarasov V, Jung P, Verdoodt B, et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle,2007, 6(13):1586-1593.
[7] He X, He L, Hannon G J. The guardian’s little helper: microRNAs in the p53 tumor suppressor network. Cancer Res,2007, 67(23):11099-11101.
[8] He L, He X, Lim L P, et al. A microRNA component of the p53 tumour suppressor network. Nature. 2007, 447(7148): 1130-1134.
[9] Raver-Shapira N, Marciano E, Meiri E, et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell,2007, 26(5):731-743.
[10] Song B,Wang Y,Kudo K,et al. miR-192 regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit.Clin.Cancer Res,2008, 14(24):8080-8086.
[11] Georges S A, Biery M C, Kim S Y, et al. Coordinated regulation of cell cycle transcripts by p53-inducible microRNAs, miR-192 and miR-215. Cancer Res,2008, 68(24):10105-10112.
[12] Park S Y, Lee J H, Ha M, et al. miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol,2009, 16(1):23-29.
[13] Le M T, Teh C, Shyh-Chang N, et al. MicroRNA-125b is a novel negative regulator of p53. Genes Dev,2009, 23(7):862-876.
[14] Zhang Y, Gao J S, Tang X, et al. MicroRNA 125a and its regulation of the p53 tumor suppressor gene. FEBS Lett,2009, 583(22):3725-3730.
[15] Tian S, Huang S, Wu S, et al. MicroRNA-1285 inhibits the expression of p53 by directly targeting its 3' untranslated region. Biochem Biophys Res Commun. 2010, 396(2):435-439.
[16] Hu W, Chan C S, Wu R, et al. Negative regulation of tumor suppressor p53 by microRNA miR-504. Mol Cell,2010, 38(5):689-699.
[17] Mraz M, Pospisilova S, Malinova K, et al. MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes. Leuk Lymphoma,2009, 50(3):506-509.
[18] Cui Q, Yu Z, Pan Y, et al. MicroRNAs preferentially target the genes with high transcriptional regulation complexity. Biochem Biophys Res Commun,2007, 352(3): 733-738.
[19] Shalgi R, Lieber D, Oren M, et al. Global and local architecture of the mammalian microRNA-transcription factor regulatory network. PLoS Comput Biol,2007, 3(7): e131.
[20] Guo A Y, Sun J, Jia P, et al. A Novel microRNA and transcription factor mediated regulatory network in schizophrenia. BMC Syst Biol,2010, 4(1):10.
[21] Ragimov N, Krauskopf A, Navot N, et al. Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif. Oncogene,1993, 8(5):1183-1193..
[22] Ho J S, Ma W, Mao D Y, et al. Benchimol S. p53-dependent transcriptional repression of c-myc is required for G1 cell cycle arrest. Mol Cell Biol,2005, 25(17):7423-7431.
[23] Sachdeva M,Zhu S,Wu F,et al.p53 represses c-Myc through induction of the tumor suppressor miR-145.Proc Natl Acad Sci VSA,2009,106(9):3207-3212.
[24] Yamakuchi M, Lowenstein C J. MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle,2009, 8(5):712-715.
[25] Brosh R, Shalgi R, Liran A, et al. p53-Repressed miRNAs are involved with E2F in a feed-forward loo Ppromoting proliferation. Mol Syst Biol,2008, 4:229.
[26] Suzuki H I, Yamagata K, Sugimoto K, et al. Modulation of microRNA processing by p53. Nature,2009, 460(7254):529-533.
[27] Kota J, Chivukula R R, O'Donnell K A, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell,2009, 137(6):1005-1017. |
